BS-194 is an orally active, selective and potent CDK inhibitor. BS-194 inhibits CDK2, CDK1, CDK5, CDK7, CDK9 (IC50s: 3, 30, 30, 250, and 90 nM respectively). BS-194 potently inhibits cancer cells proliferation. BS-194 can be used in the research of cancers like breast cancer, colon cancer[1].
A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTHR / PTHR1 (aa145-194). This antibody is tested and proven to work in the following applications: